IP Verse

United Therapeutics competitive analysis

Loading summary...

Latest patents of United Therapeutics opposed by its competitors

Explore United Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 30, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3172220
Dec 27, 2023Method For Purifying Antibodies2
EP2711024
Mar 6, 2019Buffer Solutions Having Selective Bactericidal Activity Against Gram Negative Bacteria And Methods Of Using Same2

Latest publications and patents of United Therapeutics New

Explore the latest publications and patents granted to United Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Oct 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of United Therapeutics

EP3172220
Dec 27, 2023Method For Purifying AntibodiesPatent Maintained As Amended
EP2711024
Mar 6, 2019Buffer Solutions Having Selective Bactericidal Activity Against Gram Negative Bacteria And Methods Of Using SameRevoked
EP2010236545
Sep 23, 2010Dosage Inhaler -

Latest PTAB cases involving United Therapeutics

Discover the latest PTAB cases involving United Therapeutics, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 29, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving United Therapeutics

IPR2025-01139Jun 10, 2025UNITED THERAPEUTICSACTELION PHARMACEUTICALSPending
IPR2021-00406Jan 7, 2021LIQUIDIAUNITED THERAPEUTICSFinal Written Decision
IPR2020-00769Mar 30, 2020LIQUIDIAUNITED THERAPEUTICSInstitution Denied
IPR2020-00770Mar 30, 2020LIQUIDIA TECHNOLGIESUNITED THERAPEUTICSFinal Written Decision
IPR2017-01621Jun 21, 2017WATSON LABORATORIESUNITED THERAPEUTICSTerminated-Settled
IPR2017-01622Jun 21, 2017WATSON LABORATORIESUNITED THERAPEUTICSTerminated-Settled
IPR2016-00006Oct 2, 2015STEADYMEDUNITED THERAPEUTICSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing United Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 30, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
UNITED THERAPEUTICS - 416
GENERICS UK214 - - -
LIQUIDIA - - 2 -
WATSON LABORATORIES - - 2 -